BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32451770)

  • 1. Epigenetics and survivorship in pediatric brain tumor patients.
    Bhattacharya D; Pomeroy SL; Pomeranz Krummel DA; Sengupta S
    J Neurooncol; 2020 Oct; 150(1):77-83. PubMed ID: 32451770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor.
    Harris RD; Richard MA; Gramatges MMJ; Wilhelm K; Scheurer ME; Lupo PJ; Brown AL
    Pediatr Hematol Oncol; 2023 May; 40(4):407-411. PubMed ID: 35862575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances on Epigenetic Drugs for Pediatric Brain Tumors.
    Skouras P; Markouli M; Strepkos D; Piperi C
    Curr Neuropharmacol; 2023; 21(7):1519-1535. PubMed ID: 36154607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics.
    Batora NV; Sturm D; Jones DT; Kool M; Pfister SM; Northcott PA
    Neuroscience; 2014 Apr; 264():171-85. PubMed ID: 23876321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New research directions in medulloblastoma.
    Grill J; Dufour C; Guerrini-Rousseau L; Ayrault O
    Neurochirurgie; 2021 Feb; 67(1):87-89. PubMed ID: 30904166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Drivers in Pediatric Medulloblastoma.
    Roussel MF; Stripay JL
    Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
    Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
    Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation in medulloblastoma.
    Yi J; Wu J
    Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epigenetics of brain tumors.
    Dubuc AM; Mack S; Unterberger A; Northcott PA; Taylor MD
    Methods Mol Biol; 2012; 863():139-53. PubMed ID: 22359291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic events in medulloblastoma development.
    Lindsey JC; Anderton JA; Lusher ME; Clifford SC
    Neurosurg Focus; 2005 Nov; 19(5):E10. PubMed ID: 16398460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.
    Strejczek A; Woszczyk D; Urbaniak H; Różańska M; Robak M; Matuszewska Z; Barciszewska AM
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-oncology: Genetic variation in pediatric and adult brain tumors.
    Brandes AA; Franceschi E
    Nat Rev Neurol; 2010 Dec; 6(12):653-4. PubMed ID: 21131914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medulloblastoma biology in the post-genomic era.
    Archer TC; Pomeroy SL
    Future Oncol; 2012 Dec; 8(12):1597-604. PubMed ID: 23231521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and therapeutic targets in pediatric brain tumors.
    Liu KW; Pajtler KW; Worst BC; Pfister SM; Wechsler-Reya RJ
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapy of infantile malignant brain tumors: current status?
    Kalifa C; Grill J
    J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma: what is the role of molecular genetics?
    Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic mechanisms regulating neural development and pediatric brain tumor formation.
    Faria CM; Rutka JT; Smith C; Kongkham P
    J Neurosurg Pediatr; 2011 Aug; 8(2):119-32. PubMed ID: 21806352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
    Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
    J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.